Octagam 10% Infusionslösung 10g/100ml i.v. Durchstechflasche buy online
Octagam 10% Inf Lös 10 g/100ml i.v. Durchstf
-
1,106.78 CHF
- Price in reward points: 3131
- Availability: In stock
- Brand: OCTAPHARMA AG
- Product Code: 4648465
- ATC-code J06BA02
- EAN 7680603230030
Ingredients:
Maltose, Natrium 69 mg, Immunglobulin vom Menschen 95 % , Proteine 10 g, Immunglobulin A human (IgA) 40 mg.
Description
Octagam 10% 10 g/100 ml infusion solution vial is a ready-to-use intravenous immunoglobulin preparation designed for therapeutic use. It contains 10% human immunoglobulin G (IgG) in a 100 ml vial, providing 10 grams of immunoglobulin per vial. This solution is formulated to support the immune system by supplying antibodies that help in immune modulation.
The infusion solution is intended for administration under medical supervision, typically used in various conditions where immunoglobulin therapy is indicated. Octagam 10% is supplied in a sterile vial, ensuring safety and convenience for healthcare professionals during infusion procedures.
Key features and benefits include:
- High concentration of IgG (10%) for effective dosing
- Ready-to-use vial format for ease of administration
- Produced using validated processes to ensure purity and safety
- Supports immune system function by providing a broad spectrum of antibodies
- Suitable for intravenous infusion under medical guidance
Octagam 10% is typically used in clinical settings for patients requiring immunoglobulin replacement or immunomodulatory therapy. It is important that its use is based on a healthcare professional’s assessment and prescription. Proper handling and administration protocols should be followed to ensure optimal safety and efficacy.
Reviews (0)
Free consultation with an experienced pharmacist
Describe the symptoms or the right drug - we will help you choose its dosage or analogue, place an order with home delivery or just consult.
We are 14 pharmacists and 0 bots. We will always be in touch with you and will be able to communicate at any time.













